| 1 |
Arnold M, Abnet CC, Neale RE, et al. Global burden of 5 major types of gastrointestinal cancer [J]. Gastroenterology, 2020, 159(1): 335-349. e15.
|
| 2 |
Muscaritoli M, Anker SD, Argilés J, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics" [J]. Clin Nutr, 2010, 29: 154-159.
|
| 3 |
Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: an international consensus [J]. Lancet Oncol, 2011, 12: 489-495.
|
| 4 |
Bowen TS, Schuler G, Adams V. Skeletal muscle wasting in cachexia and sarcopenia: molecularpathophysiology and impact of exercise training [J]. J Cachexia Sarcopenia Muscle, 2015, 6: 197-207.
|
| 5 |
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on defifinition and diagnosis: report of the European Working Group on Sarcopenia in Older People [J]. Age Ageing, 2010, 39(4): 412-423.
|
| 6 |
Pamoukdjian F, Bouillet T, Levy V, et al. Prevalence and predictive value of pre-therapeutic sarcopenia in cancer patients: a systematic review [J]. Clin Nutr, 2018, 37: 1101-1113.
|
| 7 |
van Vugt JLA, Buettner S, Levolger S, et al. Low skeletal muscle mass is associated with increased hospital expenditure in patients undergoing cancer surgery of the alimentary tract [J]. PLoS One, 2017, 12: e0186547.
|
| 8 |
Sergi G, Trevisan C, Veronese N, et al. Imaging of sarcopenia [J]. Eur J Radiol, 2016, 85: 1519-1524.
|
| 9 |
Gomez-Perez SL, Haus JM, Sheean P, et al. Measuring abdominal circumference and skeletal muscle from a single cross-sectional computed tomography image: A step-by-step guide for clinicians using national institutes of health image J [J]. JPEN J Parenter Enteral Nutr, 2016, 40: 308-318.
|
| 10 |
Ní Bhuachalla ÉB, Daly LE, Power DG, et al. Computed tomography diagnosed cachexia and sarcopenia in 725 oncology patients: is nutritional screening capturing hidden malnutrition [J]? J Cachexia Sarcopenia Muscle, 2018, 9(2): 295-305.
|
| 11 |
Jogiat UM, Sasewich H, Turner SR, et al. Sarcopenia determined by skeletal muscle index predicts overall survival, disease-free survival, and postoperative complications in resectable esophageal cancer: A systematic review and meta-analysis [J]. Ann Surg, 2022, 276(5): e311-e318.
|
| 12 |
Mayanagi S, Ishikawa A, Matsui K, Matsuda S, Irino T, Nakamura R, et al. Association of preoperative sarcopenia with postoperative dysphagia in patients with thoracic esophageal cancer [J]. Dis Esophagus, 2021, 34(9): doaa121.
|
| 13 |
Ma BW, Chen XY, Fan SD, et al. Impact of sarcopenia on clinical outcomes after radical gastrectomy for patients without nutritional risk [J]. Nutrition, 2019, 61: 61-66.
|
| 14 |
Kawamura T, Makuuchi R, Tokunaga M, et al. Long-term outcomes of gastric cancer patients with preoperative sarcopenia [J]. Ann Surg Oncol, 2018, 25(6): 1625-1632.
|
| 15 |
Park SE, Hwang IG, Choi CH, et al. Sarcopenia is poor prognostic factor in older patients with locally advanced rectal can-cer who received preoperative or postoperative chemoradiotherapy [J]. Medicine (Balti-more), 2018, 97: e13363.
|
| 16 |
Miyamoto Y, Baba Y, Sakamoto Y, et al. Sarcopenia is a negative prognostic factor after curative resection of colorectal cancer [J]. Ann Surg Oncol, 2015, 22: 2663-2668.
|
| 17 |
Papaconstantinou D, Vretakakou K, Paspala A, et al. The impact of preoperative sarcopenia on postoperative complications following esophagectomy for esophageal neoplasia: a systematic review and metaanalysis [J]. Dis Esophagus, 2020, 33: doaa002.
|
| 18 |
Nishigori T, Okabe H, Tanaka E, et al. Sarcopenia as a predictor of pulmonary complications after esophagectomy for thoracic esophageal cancer [J]. J Surg Oncol, 2016, 113: 678-684.
|
| 19 |
Kurita D, Oguma J, Ishiyama K, et al. Handgrip strength predicts postoperative pneumonia after thoracoscopic-laparoscopic esophagectomy for patients with esophageal cancer [J]. Ann Surg Oncol, 2020, 37: 3173-3181.
|
| 20 |
Huang DD, Wang SL, Zhuang CL, et al. Sarcopenia, as defined by low muscle mass, strength and physical performance, predicts complications after surgery for colorectal cancer [J]. Colorectal Dis, 2015, 17: O256-O264.
|
| 21 |
Peng P, Hyder O, Firoozmand A, et al. Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma [J]. J Gastrointest Surg, 2012, 16: 1478-1486.
|
| 22 |
Kodera Y. More than 6 months of postoperative adjuvant chemotherapy results in loss of skeletal muscle: a challenge to the current standard of care [J]. Gastric Cancer, 2015, 18: 203-204.
|
| 23 |
Li YP, Reid MB. Effect of tumor necrosis factor-alpha on skeletal muscle metabolism [J]. Curr Opin Rheumatol, 2001, 13: 483-487.
|
| 24 |
Gilliam LA, Moylan JS, Ferreira LF, et al. TNF/TNFR1 signaling mediates doxorubicin-induced diaphragm weakness [J]. Am J Physiol Lung Cell Mol Physiol, 2011, 300: L225-31.
|
| 25 |
Gilliam LA, Moylan JS, Callahan LA, et al. Doxorubicin causes diaphragm weakness in murine models of cancer chemotherapy [J]. Muscle Nerve, 2011, 43: 94-102.
|
| 26 |
Chen JL, Colgan TD, Walton KL, et al. The TGF-beta signalling network in muscle development, adaptation and disease [J]. Adv Exp Med Biol, 2016, 900: 97-131.
|
| 27 |
Ramesh G, Reeves WB. TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity [J]. J Clin Invest, 2002, 110: 835-842.
|
| 28 |
Ederer AK, Didier KD, Reiter LK, et al. Influence of adjuvant therapy in cancer survivors on endothelial function and skeletal muscle deoxygenation [J]. PLoS One, 2016, 11: e0147691.
|
| 29 |
Daly LE, Ni Bhuachalla EB, Power DG, et al. Loss of skeletal muscle during systemic chemotherapy is prognostic of poor survival in patients with foregut cancer [J]. J Cachexia Sarcopenia Muscle, 2018, 9: 315-325.
|
| 30 |
Barreiro E, Gea J. PARP-1 and PARP-2 activity in cancer induced cachexia: potential therapeutic implications [J]. Biol Chem, 2018, 399: 179-186.
|
| 31 |
Mohamed JS, Wilson JC, Myers MJ, et al. Dysregulation of SIRT-1 in aging mice increases skeletal muscle fatigue by a PARP-1-dependent mechanism [J]. Aging (Albany NY), 2014, 6: 820-834.
|
| 32 |
Pirinen E, Canto C, Jo YS, et al. Pharmacological Inhibition of poly(ADP-ribose) polymerases improves fitness and mitochondrial function in skeletal muscle [J]. Cell Metab, 2014, 19: 1034-1041.
|
| 33 |
Toledo M, Penna F, Oliva F, et al. A multifactorial anticachectic approach for cancer cachexia in a rat model undergoing chemotherapy [J]. J Cachexia Sarcopenia Muscle, 2016, 7: 48-59.
|
| 34 |
Catikkas NM, Bahat Z, Oren MM, et al. Older cancer patients receiving radiotherapy: a systematic review for the role of sarcopenia in treatment outcomes [J]. Aging Clin Exp Res, 2022, 34(8): 1747-1759.
|
| 35 |
Lutz CT, Quinn LS. Sarcopenia, obesity, and natural killer cell immune senescence in aging: altered cytokine levels as a common mechanism [J]. Aging, 2012, 4, 535-546.
|
| 36 |
Girard D, Paquet ME, Paquin R, et al. Differential effects of interleukin-15 (IL-15) and IL-2 on human neutrophils: modulation of phagocytosis, cytoskeleton rearrangement, gene expression, and apoptosis by IL-15 [J]. Blood, 1996, 88(8): 3176-3184
|
| 37 |
Nelke C, Dziewas R, Minnerup J, et al. Skeletal muscle as potential central link between sarcopenia and immune senescence [J]. EBioMedicine, 2019, 49: 381-388.
|
| 38 |
Haddad F, Zaldivar F, Cooper DM, et al. IL-6-induced skeletal muscle atrophy [J]. J Appl Physiol (1985), 2005, 98(3): 911-917.
|
| 39 |
Akce M, Liu Y, Zakka K, et al. Impact of Sarcopenia, BMI, and inflflammatory biomarkers on survival in advanced hepatocellular carcinoma treated with anti-Pd-1 antibody [J]. Am J Clin Oncol, 2021, 44(2): 74-81.
|
| 40 |
Xiao LS, Li RN, Cui H, et al. Use of computed tomography-derived body composition to determine the prognosis of patients with primary liver cancer treated with immune checkpoint inhibitors: A retrospective cohort study [J]. BMC Cancer, 2022, 22(1): 737.
|
| 41 |
Fujii H, Makiyama A, Iihara H, et al. Cancer cachexia reduces the effificacy of nivolumab treatment in patients with advanced gastric cancer [J]. Anticancer Res, 2020, 40, 7067-7075.
|
| 42 |
Kano M, Hihara J, Tokumoto N, et al. Association between skeletal muscle loss and the response to nivolumab immunotherapy in advanced gastric cancer patients [J]. Int J Clin Oncol, 2021, 26, 523-531.
|
| 43 |
Prado CM, Lieffers JR, Bowthorpe L, et al. Sarcopenia and physical function in overweight patients with advanced cancer [J]. Can J Diet Pract Res, 2013, 74: 69-74.
|
| 44 |
Moro T, Brightwell CR, Deer RR, et al. Muscle protein anabolic resistance to essential amino acids does not occur in healthy older adults before or after resistance exercise training [J]. J Nutr, 2018, 148: 900-909.
|
| 45 |
Volpi E, Kobayashi H, Sheffield-Moore M, et al. Essential amino acids are primarily responsible for the amino acid stimulation of muscle protein anabolism in healthy elderly adults [J]. Am J Clin Nutr, 2003, 78: 250-258.
|
| 46 |
Paddon-Jones D, Campbell WW, Jacques PF, et al. Protein and healthy aging [J]. Am J Clin Nutr, 2015, 101: 1339s-1345s.
|
| 47 |
van der Wielen RP, Lowik MR, van den Berg H, et al. Serum vitamin D concentrations among elderly people in Europe [J]. Lancet, 1995, 346: 207-210.
|
| 48 |
Morley JE, Argiles JM, Evans WJ, et al. Nutritional recommendations for the management of sarcopenia [J]. J Am Med Dir Assoc, 2010, 11: 391-396.
|
| 49 |
Rolland Y, Dupuy C, Abellan van Kan G, et al. Treatment strategies for sarcopenia and frailty [J]. Med Clin North Am, 2011, 95(3): 427-348, ix.
|
| 50 |
Murphy RA, Mourtzakis M, Chu QS, et al. Supplementation with fish oil increases first-line chemotherapy efficacy in patients with advanced nonsmall cell lung cancer [J]. Cancer, 2011, 117: 3774-3780.
|
| 51 |
Vallejo J, Spence M, Cheng AL, et al. Cellular and physiological effects of dietary supplementation with beta-Hydroxy-beta-Methylbutyrate (HMB) and beta-Alanine in late middle-aged mice [J]. PLoS One, 2016, 11: e0150066.
|
| 52 |
Alway SE, Pereira SL, Edens NK, et al. beta-Hydroxy beta-methylbutyrate (HMB) enhances the proliferation of satellite cells in fast muscles of aged rats during recovery from disuse atrophy [J]. Exp Gerontol, 2013, 48: 973-984.
|
| 53 |
Stout JR, Smith-Ryan AE, Fukuda DH, et al. Effect of calcium beta-hydroxy-beta-methylbutyrate (CaHMB) with and without resistance training in men and women 65+yrs:a randomized, double-blind pilot trial [J]. Exp Gerontol, 2013, 48: 1303-1310.
|